Continuous glucose monitoring and closed‐loop systems

Background  The last two decades have witnessed unprecedented technological progress in the development of continuous glucose sensors, resulting in the first generation of commercial glucose monitors. This has fuelled the development of prototypes of a closed‐loop system based on the combination of a continuous monitor, a control algorithm, and an insulin pump.

[1]  G. Kessler,et al.  CONTINUOUS IN VIVO DETERMINATION OF BLOOD GLUCOSE IN HUMAN SUBJECTS , 1960, Annals of the New York Academy of Sciences.

[2]  J. Schlichtkrull,et al.  [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.

[3]  A. H. Kadish,et al.  AUTOMATION CONTROL OF BLOOD SUGAR. I. A SERVOMECHANISM FOR GLUCOSE MONITORING AND CONTROL. , 1964, The American journal of medical electronics.

[4]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[5]  G. Grodsky,et al.  A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. , 1972, The Journal of clinical investigation.

[6]  W Zingg,et al.  Clinical Control of Diabetes by the Artificial Pancreas , 1974, Diabetes.

[7]  A H Clemens,et al.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  Charles K. Botz.  An Improved Control Algorithm for an Artificial ß-Cell , 1976, IEEE Transactions on Biomedical Engineering.

[9]  C. Botz.  An improved control algorithm for an artificial beta-cell. , 1976, IEEE transactions on bio-medical engineering.

[10]  B. Zinman,et al.  Normalization of Glycemia in Diabetics During Meals with Insulin and Glucagon Delivery by the Artificial Pancreas , 1977, Diabetes.

[11]  E. Kraegen,et al.  Control of blood glucose in diabetics using an artificial pancreas. , 1977, Australian and New Zealand journal of medicine.

[12]  A H Clemens,et al.  The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS). , 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.

[14]  R. Kawamori,et al.  The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis. , 1979, Medical progress through technology.

[15]  A H Clemens,et al.  Feedback control dynamics for glucose controlled insulin infusion system. , 1979, Medical progress through technology.

[16]  A. M. Albisser,et al.  Comparison of Algorithms for the Closed-Loop Control of Blood Glucose Using the Artificial Beta Cell , 1981, IEEE Transactions on Biomedical Engineering.

[17]  Y. Yamasaki,et al.  WEARABLE ARTIFICIAL ENDOCRINE PANCREAS WITH NEEDLE-TYPE GLUCOSE SENSOR , 1982, The Lancet.

[18]  Claudio Cobelli,et al.  An integrated mathematical model of the dynamics of blood glucose and its hormonal control , 1982 .

[19]  U. Fischer,et al.  Kinetic Modeling of the Glucoregulatory System to Improve Insulin Therapy , 1985, IEEE Transactions on Biomedical Engineering.

[20]  R. Eaton,et al.  Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. , 1986, The Journal of clinical endocrinology and metabolism.

[21]  J. Robert,et al.  Glycemic Control with Closed-Loop Intraperitoneal Insulin in Type I Diabetes , 1986, Diabetes Care.

[22]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[23]  J. Louis-Sylvestre.  [The cephalic phase of insulin secretion]. , 1987, Diabete & metabolisme.

[24]  S. Kageyama,et al.  [Artificial endocrine pancreas]. , 1989, Nihon rinsho. Japanese journal of clinical medicine.

[25]  D Rodbard,et al.  Computer Simulation of Plasma Insulin and Glucose Dynamics After Subcutaneous Insulin Injection , 1989, Diabetes Care.

[26]  D. Howey,et al.  In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. , 1992, Biosensors & bioelectronics.

[27]  Ewart R. Carson,et al.  Causal Probabilistic Network Modeling - An Illustration of its Role in the Management of Chronic Diseases , 1992, IBM Syst. J..

[28]  M. Shichiri,et al.  Development of a Miniaturized Glucose Monitoring System by Combining a Needle-Type Glucose Sensor With Microdialysis Sampling Method: Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients , 1994, Diabetes Care.

[29]  J. Wojcicki,et al.  “J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  Wójcicki Jm,et al.  J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .

[31]  J. Holst,et al.  Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8. , 1995, The American journal of physiology.

[32]  M. Shichiri,et al.  Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. , 1997, Frontiers of medical and biological engineering : the international journal of the Japan Society of Medical Electronics and Biological Engineering.

[33]  D. Cox,et al.  Understanding Error Grid Analysis , 1997, Diabetes Care.

[34]  P. Wach,et al.  Neural predictive controller for insulin delivery using the subcutaneous route , 1998, IEEE Transactions on Biomedical Engineering.

[35]  M. Shichiri,et al.  Enhanced, simplified glucose sensors: long-term clinical application of wearable artificial endocrine pancreas. , 1998, Artificial organs.

[36]  John J Mastrototaro,et al.  Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. , 1999, American journal of physiology. Endocrinology and metabolism.

[37]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[38]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[39]  P Wach,et al.  Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion. , 1999, American journal of physiology. Endocrinology and metabolism.

[40]  J. Mastrototaro,et al.  The MiniMed Continuous Glucose Monitoring System (CGMS). , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[41]  七里 元亮.  Artificial endocrine pancreas : development and clinical applications , 2000 .

[42]  J. Mastrototaro,et al.  Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. , 2000, Diabetes technology & therapeutics.

[43]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[44]  B. W. Bequette,et al.  Estimation-based model predictive control of blood glucose in type I diabetics: a simulation study , 2001, Proceedings of the IEEE 27th Annual Northeast Bioengineering Conference (Cat. No.01CH37201).

[45]  U. Haueter,et al.  Recording of subcutaneous glucose dynamics by a viscometric affinity sensor , 2001, Diabetologia.

[46]  U. Hoss,et al.  A novel method for continuous online glucose monitoring in humans: the comparative microdialysis technique. , 2001, Diabetes technology & therapeutics.

[47]  U Hoss,et al.  Recent advances in continuous glucose monitoring. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[48]  L. Heinemann,et al.  Sensors for glucose monitoring: technical and clinical aspects , 2001, Diabetes/metabolism research and reviews.

[49]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[50]  J L Selam,et al.  External and implantable insulin pumps: current place in the treatment of diabetes. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[51]  Benjamin Glaser,et al.  Reproducibility of glucose measurements using the glucose sensor. , 2002, Diabetes care.

[52]  John Pickup,et al.  Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. , 2002, Diabetes care.

[53]  S. Takasawa,et al.  Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. , 2002, Diabetes.

[54]  O. McGuinness,et al.  Physiological consequences of phasic insulin release in the normal animal. , 2002, Diabetes.

[55]  A. Moran,et al.  Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. , 2002, Diabetes care.

[56]  R. DeFronzo,et al.  Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. , 2002, Diabetes.

[57]  Eric Renard,et al.  Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. , 2002, Current opinion in pharmacology.

[58]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[59]  E Renard,et al.  [From external to implantable insulin pump, can we close the loop?]. , 2002, Diabetes & metabolism.

[60]  Gernot Brunner,et al.  A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. , 2002, Diabetes care.

[61]  R. Schiaffini,et al.  The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk , 2002, Diabetes/metabolism research and reviews.

[62]  Roman Hovorka,et al.  Feasibility of the SC-SC Route for an Extracorporeal Artificial Pancreas , 2002 .

[63]  Lutz Heinemann,et al.  Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects. , 2003, Diabetes technology & therapeutics.

[64]  Marko Bacic,et al.  Model predictive control , 2003 .

[65]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[66]  Howard A Wolpert.  A clinician's perspective on some of the challenges in "closing the loop". , 2003, Diabetes technology & therapeutics.

[67]  V. Lassmann-Vague,et al.  Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps. , 2003, Diabetes & metabolism.

[68]  J. Pickup,et al.  Performance assessment of the Medtronic‐MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[69]  Reproducibility of the continuous glucose monitoring system matches previous reports and the intended use of the product. , 2003, Diabetes care.

[70]  P. Böhme,et al.  Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. , 2003, Diabetes care.

[71]  F. Chee,et al.  Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time , 2003, IEEE Transactions on Information Technology in Biomedicine.

[72]  Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. , 2003, Diabetes & metabolism.

[73]  Michael Schoemaker,et al.  The SCGM1 System: subcutaneous continuous glucose monitoring based on microdialysis technique. , 2003, Diabetes technology & therapeutics.

[74]  P. Schaepelynck-Belicar,et al.  Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). , 2003, Diabetes & metabolism.

[75]  H Gin,et al.  Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. , 2003, Diabetes & metabolism.

[76]  Johnny Ludvigsson,et al.  Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. , 2003, Pediatrics.

[77]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[78]  James D Dziura,et al.  Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.

[79]  Bruce A Buckingham,et al.  Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. , 2004, The Journal of pediatrics.

[80]  G. Steil,et al.  Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. , 2004, Diabetes.

[81]  Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. , 2004, Diabetes care.

[82]  GR Ambler,et al.  Does continuous glucose monitoring have clinical utility in contemporary management of diabetes? , 2004, Journal of paediatrics and child health.

[83]  Roman Hovorka,et al.  Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.

[84]  A. Caumo,et al.  First-phase insulin secretion: does it exist in real life? Considerations on shape and function. , 2004, American journal of physiology. Endocrinology and metabolism.

[85]  C. Chia,et al.  Glucose sensors: toward closed loop insulin delivery. , 2004, Endocrinology and metabolism clinics of North America.

[86]  M. Mlynarek,et al.  An Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients , 2004, The Annals of pharmacotherapy.

[87]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[88]  James D Dziura,et al.  Experience with the continuous glucose monitoring system in a medical intensive care unit. , 2004, Diabetes technology & therapeutics.

[89]  J. Mastrototaro,et al.  Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. , 2004, Diabetes technology & therapeutics.

[90]  Roman Hovorka,et al.  Grading system to assess clinical performance of closed-loop glucose control. , 2005, Diabetes technology & therapeutics.

[91]  L. Schaupp,et al.  On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.